Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

SHSE:605016 Stock Report

Market Cap: CN¥5.6b

Shandong Bailong Chuangyuan Bio-Tech Dividends and Buybacks

Dividend criteria checks 2/6

Shandong Bailong Chuangyuan Bio-Tech is a dividend paying company with a current yield of 1.07% that is well covered by earnings. Next payment date is on 27th December, 2024 with an ex-dividend date of 27th December, 2024.

Key information

1.1%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield0.7%
Dividend Growth43.1%
Next dividend pay date27 Dec 24
Ex dividend date27 Dec 24
Dividend per shareCN¥0.185
Payout ratio29%

Recent dividend and buyback updates

No updates

Recent updates

Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals

Nov 06
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Oct 14
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Sep 29
Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Aug 23
Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Jun 26
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

May 06
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

May 03
Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Mar 27
If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, 605016 has been paying a dividend for less than 10 years.

Growing Dividend: 605016's dividend payments have increased, but the company has only paid a dividend for 3 years.


Dividend Yield vs Market

Shandong Bailong Chuangyuan Bio-Tech Dividend Yield vs Market
How does 605016 dividend yield compare to the market?
SegmentDividend Yield
Company (605016)1.1%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.1%
Industry Average (Food)2.2%
Analyst forecast (605016) (up to 3 years)0.7%

Notable Dividend: 605016's dividend (1.07%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 605016's dividend (1.07%) is low compared to the top 25% of dividend payers in the CN market (2.15%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (29.3%), 605016's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 605016 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:18
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xia ShengCitic Securities Co., Ltd.
Lin YangGuosen Securities Co., Ltd.
Wei LiuHaitong International Research Limited